NasdaqCM:VKTXBiotechs
Assessing Viking Therapeutics (VKTX) Valuation After Recent Share Price Volatility And Strong Multi Year Gains
Viking Therapeutics (VKTX) has drawn investor attention after recent share performance data highlighted a mixed picture, with a 1 day return of about a 5% decline and a very large 3 year total return multiple.
See our latest analysis for Viking Therapeutics.
At the current share price of US$29.00, Viking Therapeutics has seen mixed momentum, with a 7 day share price return of 1.97%, a 30 day share price decline of 15.55%, and a 3 year total shareholder return of about 2.6x. Together, these...